BCRB 2018

Combined chemo- and radiotherapy treatment

• Spatial co-operation (e.g. breast carcinoma) • Independent cell kill (e.g. Hodgkin lymphoma) • Interaction (e.g. H&N, cervix, NSCLC) • “diluted” toxicity (e.g. Hodgkin lymphoma)

ESTRO 2018